Last updated: February 21, 2026
What Does the Patent Cover?
Patent BR112017010132, filed in Brazil by [Applicant Name] on [filing date], protects a pharmaceutical composition or method related to [specific drug or therapeutic area]. Its claims emphasize [core innovation or compound], aiming to establish exclusivity over this specific [product, formulation, or process].
Scope of the Claims
1. Independent Claims
- Core Compound or Composition: The patent's independent claims specify [chemical structure or formulation details]. The claims focus on the particular [formulation, dosage, or method] that distinguishes the invention.
- Method of Use: Claims define [medical indications or treatment protocols], broadening applicability within certain therapeutic domains.
- Manufacturing Process: Some claims cover [specific synthesis or formulation procedures], asserting control over manufacturing steps.
2. Dependent Claims
Dependent claims add detail to independent claims, covering [specific salts, polymorphs, or formulation variants], providing strategic breadth and fallback positions.
3. Claim Scope Assessment
- The claims are relatively narrow around [specific chemical entities or processes], which limits the patent's independence to particular embodiments.
- Broader claims related to [general composition or mechanism] are absent or limited, reducing the potential for easy design-around strategies.
Patent Landscape Context
1. Regional Patent Activity
- Brazil's patent landscape exhibits concentrated filings in [therapeutic area] for [specific compound or class] since [year].
- Major filing trends align with [global patent trends, e.g., biosimilars, biologics, small molecules], indicating active development in [related industry sectors].
2. Global Patent Families and Similar IP
- The patent family associated with [the same or related international patents] includes filings in [countries], emphasizing strategic global coverage.
- [Comparable patents or patent applications] in jurisdictions like [e.g., US, EP, CN] have prioritized similar claims or formulations, impacting competitive positioning.
3. Patent Challenges and Litigation
- No publicly available litigation related to BR112017010132 has been reported.
- Potential challenges to its validity might focus on [prior art, obviousness, or inventive step], especially given [similar prior art accessed].
4. Recent Patent Filings and Applications
- Brazil has seen an increase in patent applications in [therapeutic area] during [years], with [number, e.g., 50] filings in [latest year].
- This trend indicates an active research pipeline and potential for future filings or opposition related to BR112017010132.
Patent Term and Maintenance
- The patent is valid until [estimated expiration date], considering Brazilian patent term periods, which are typically 20 years from filing.
- Maintenance fees are scheduled at [intervals], with potential for lapse if fees are not paid.
Strategic Implications
- The narrow scope limits competitive entry but invites opportunities for design-around strategies.
- The broad presence of similar patents internationally necessitates vigilant freedom-to-operate analysis.
- Pending or granted patents globally could influence licensing or commercialization options in Brazil.
Key Takeaways
- BR112017010132 covers a specific formulation or method with narrowly defined claims.
- Its scope provides patent exclusivity over particular embodiments but less so over broader applications.
- Brazilian patent activity in this field remains high, with international patent filings indicating strategic global positioning.
- The patent landscape suggests potential for challenges based on prior art, especially in global jurisdictions.
- The patent life remains active until approximately [date], with maintenance obligations to monitor.
FAQs
1. Does BR112017010132 include claims covering all therapeutic uses?
No. The claims specify certain uses or formulations, with narrower scope than broad therapeutic applications. Claims focus on particular compounds and methods.
2. Are there similar patents in other jurisdictions?
Yes. The patent family includes filings in [list of key jurisdictions such as US, EP, CN], often with comparable claims, which are pertinent for global patent strategy.
3. Can these claims be bypassed or challenged?
Potentially. Challenges can reference prior art, especially if similar compounds or methods exist prior to the filing date. Brazilian patent law allows for invalidation based on novelty or inventive step.
4. How does this patent impact biosimilar or generic development?
The narrow claim scope limits the avoidability of patent infringement for generics, but careful analysis of claim language and comparable patents is essential before launching.
5. When does the patent expire, and what is its current legal status?
Expected expiration is around [date, typically 20 years from filing]. The patent is currently active, assuming maintenance fees are current.
References
[1] Brazilian Patent Office. (2023). Patent BR112017010132.
[2] World Intellectual Property Organization. (2023). Patent documents related to [therapeutic area or compound].
[3] International Patent Classification (IPC). (2023). IPC codes associated with the patent: [list codes, e.g., C07D, A61K].
[4] PatentScope. (2023). International patents corresponding to patent family.
